Cacan et al. (2016) reported that the loss of apoptosis antigen 1 expression impacts drug resistance, which is mediated by histone deacetylase 1 (HDAC1) in chemoresistant ovarian cancer cells (Cacan, 2016). This evidence concerns the gene HDAC1 and ovarian cancer.